Functional gastroduodenal disorders J Tack, NJ Talley, M Camilleri, G Holtmann, P Hu, JR Malagelada, ... Gastroenterology 130 (5), 1466-1479, 2006 | 3076 | 2006 |
Immune activation in patients with irritable bowel syndrome T Liebregts, B Adam, C Bredack, A Röth, S Heinzel, S Lester, ... Gastroenterology 132 (3), 913-920, 2007 | 839 | 2007 |
Functional dyspepsia NJ Talley, AC Ford New England Journal of Medicine 373 (19), 1853-1863, 2015 | 653 | 2015 |
AGA technical review: evaluation of dyspepsia NJ Talley, MD Silverstein, L Agréus, O Nyrén, A Sonnenberg, G Holtmann Gastroenterology 114 (3), 582-595, 1998 | 629 | 1998 |
Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis D So, K Whelan, M Rossi, M Morrison, G Holtmann, JT Kelly, ... The American journal of clinical nutrition 107 (6), 965-983, 2018 | 567 | 2018 |
Pathophysiology of irritable bowel syndrome GJ Holtmann, AC Ford, NJ Talley The lancet Gastroenterology & hepatology 1 (2), 133-146, 2016 | 537 | 2016 |
A placebo-controlled trial of itopride in functional dyspepsia G Holtmann, NJ Talley, T Liebregts, B Adam, C Parow New England Journal of Medicine 354 (8), 832-840, 2006 | 434 | 2006 |
Functional dyspepsia P Enck, F Azpiroz, G Boeckxstaens, S Elsenbruch, C Feinle-Bisset, ... Nature Reviews Disease Primers 3 (1), 1-20, 2017 | 365 | 2017 |
New algorithm for the treatment of gastro‐oesophageal reflux disease GN Tytgat, K McColl, J Tack, G Holtmann, RH Hunt, P Malfertheiner, ... Alimentary pharmacology & therapeutics 27 (3), 249-256, 2008 | 349 | 2008 |
Treatment of irritable bowel syndrome with herbal preparations: results of a double‐blind, randomized, placebo‐controlled, multi‐centre trial A Madisch, G Holtmann, K Plein, J Hotz Alimentary pharmacology & therapeutics 19 (3), 271-279, 2004 | 321 | 2004 |
G-protein β3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia G Holtmann, W Siffert, S Haag, N Mueller, M Langkafel, W Senf, R Zotz, ... Gastroenterology 126 (4), 971-979, 2004 | 308 | 2004 |
The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli SM Brierley, PA Hughes, AJ Page, KY Kwan, CM Martin, TA O'Donnell, ... Gastroenterology 137 (6), 2084-2095. e3, 2009 | 306 | 2009 |
Chronic pancreatitis. EP DiMagno The exocrine pancreas: Pathobiology, and disease, 541-575, 1986 | 303 | 1986 |
Asia‐Pacific consensus on the management of gastroesophageal reflux disease: update KM Fock, NJ Talley, R Fass, KL Goh, P Katelaris, R Hunt, M Hongo, ... Journal of gastroenterology and hepatology 23 (1), 8-22, 2008 | 297 | 2008 |
Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index Talley, Haque, Wyeth, Stace, Tytgat, Stanghellini, Holtmann, Verlinden Alimentary pharmacology & therapeutics 13 (2), 225-235, 1999 | 290 | 1999 |
Selective role for TRPV4 ion channels in visceral sensory pathways SM Brierley, AJ Page, PA Hughes, B Adam, T Liebregts, NJ Cooper, ... Gastroenterology 134 (7), 2059-2069, 2008 | 280 | 2008 |
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole G Holtmann, C Cain, P Malfertheiner Gastroenterology 117 (1), 11-16, 1999 | 273 | 1999 |
Prokinetics in patients with gastroparesis: a systematic analysis A Sturm, G Holtmann, H Goebell, G Gerken Digestion 60 (5), 422-427, 1999 | 270 | 1999 |
Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review AA Mikocka-Walus, DA Turnbull, NT Moulding, IG Wilson, JM Andrews, ... Inflammatory bowel diseases 13 (2), 225-234, 2007 | 264 | 2007 |
Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six‐week placebo‐controlled, double‐blind, multicentre trial G Holtmann, B Adam, S Haag, W Collet, E Grünewald, T Windeck Alimentary pharmacology & therapeutics 18 (11‐12), 1099-1105, 2003 | 232 | 2003 |